Keywords
Last Name
Institution

Zahi A. Fayad

TitleDIRECTOR Translational and Molecular Imaging Institute
InstitutionMount Sinai
Address
    Other Positions
    TitlePROFESSOR
    InstitutionMount Sinai
    DepartmentRadiology

    TitlePROFESSOR
    InstitutionMount Sinai
    DepartmentCardiology


     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Eldib M, Bini J, Calcagno C, Robson PM, Mani V, Fayad ZA. Attenuation correction for flexible magnetic resonance coils in combined magnetic resonance/positron emission tomography imaging. Invest Radiol. 2014 Feb; 49(2):63-9.
      View in: PubMed
    2. Zhao Y, van Rooy I, Hak S, Fay F, Tang J, Davies Cde L, Skobe M, Fisher EA, Radu A, Fayad ZA, de Mello Donegá C, Meijerink A, Mulder WJ. Near-infrared fluorescence energy transfer imaging of nanoparticle accumulation and dissociation kinetics in tumor-bearing mice. ACS Nano. 2013 Nov 26; 7(11):10362-70.
      View in: PubMed
    3. Gianella A, Mieszawska AJ, Hoeben FJ, Janssen HM, Jarzyna PA, Cormode DP, Costa KD, Rao S, Farokhzad OC, Langer R, Fayad ZA, Mulder WJ. Synthesis and in vitro evaluation of a multifunctional and surface-switchable nanoemulsion platform. Chem Commun (Camb). 2013 Oct 21; 49(82):9392-4.
      View in: PubMed
    4. Allijn IE, Leong W, Tang J, Gianella A, Mieszawska AJ, Fay F, Ma G, Russell S, Callo CB, Gordon RE, Korkmaz E, Post JA, Zhao Y, Gerritsen HC, Thran A, Proksa R, Daerr H, Storm G, Fuster V, Fisher EA, Fayad ZA, Mulder WJ, Cormode DP. Gold nanocrystal labeling allows low-density lipoprotein imaging from the subcellular to macroscopic level. ACS Nano. 2013 Nov 26; 7(11):9761-70.
      View in: PubMed
    5. Fernández-Ortiz A, Jiménez-Borreguero LJ, Peñalvo JL, Ordovás JM, Mocoroa A, Fernández-Friera L, Laclaustra M, García L, Molina J, Mendiguren JM, López-Melgar B, de Vega VM, Alonso-Farto JC, Guallar E, Sillesen H, Rudd JH, Fayad ZA, Ibañez B, Sanz G, Fuster V. The Progression and Early detection of Subclinical Atherosclerosis (PESA) study: Rationale and design. Am Heart J. 2013 Dec; 166(6):990-8.
      View in: PubMed
    6. Kim Y, Fay F, Cormode DP, Sanchez-Gaytan BL, Tang J, Hennessy EJ, Ma M, Moore K, Farokhzad OC, Fisher EA, Mulder WJ, Langer R, Fayad ZA. Single step reconstitution of multifunctional high-density lipoprotein-derived nanomaterials using microfluidics. ACS Nano. 2013 Nov 26; 7(11):9975-83.
      View in: PubMed
    7. Duivenvoorden R, Mani V, Woodward M, Kallend D, Suchankova G, Fuster V, Rudd JH, Tawakol A, Farkouh ME, Fayad ZA. Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study. JACC Cardiovasc Imaging. 2013 Oct; 6(10):1087-94.
      View in: PubMed
    8. Subramanian S, Emami H, Vucic E, Singh P, Vijayakumar J, Fifer KM, Alon A, Shankar SS, Farkouh M, Rudd JH, Fayad ZA, Van Dyke TE, Tawakol A. High-dose atorvastatin reduces periodontal inflammation: a novel pleiotropic effect of statins. J Am Coll Cardiol. 2013 Dec 24; 62(25):2382-91.
      View in: PubMed
    9. Mieszawska AJ, Kim Y, Gianella A, van Rooy I, Priem B, Labarre MP, Ozcan C, Cormode DP, Petrov A, Langer R, Farokhzad OC, Fayad ZA, Mulder WJ. Synthesis of polymer-lipid nanoparticles for image-guided delivery of dual modality therapy. Bioconjug Chem. 2013 Sep 18; 24(9):1429-34.
      View in: PubMed
    10. Calcagno C, Ramachandran S, Izquierdo-Garcia D, Mani V, Millon A, Rosenbaum D, Tawakol A, Woodward M, Bucerius J, Moshier E, Godbold J, Kallend D, Farkouh ME, Fuster V, Rudd JH, Fayad ZA. The complementary roles of dynamic contrast-enhanced MRI and (18)F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis. Eur J Nucl Med Mol Imaging. 2013 Dec; 40(12):1884-93.
      View in: PubMed
    11. Lairez O, Fayad ZA. Imaging of atherosclerosis: Can molecular imaging do more? Arch Cardiovasc Dis. 2013 Nov; 106(11):551-3.
      View in: PubMed
    12. Cormode DP, Fisher EA, Stroes ES, Mulder WJ, Fayad ZA. High-density lipoprotein is a nanoparticle, but not all nanoparticles are high-density lipoprotein. Proc Natl Acad Sci U S A. 2013 Sep 17; 110(38):E3548.
      View in: PubMed
    13. Tawakol A, Fayad ZA, Mogg R, Alon A, Klimas MT, Dansky H, Subramanian SS, Abdelbaky A, Rudd JH, Farkouh ME, Nunes IO, Beals CR, Shankar SS. Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study. J Am Coll Cardiol. 2013 Sep 3; 62(10):909-17.
      View in: PubMed
    14. Calcagno C, Robson PM, Ramachandran S, Mani V, Kotys-Traughber M, Cham M, Fischer SE, Fayad ZA. SHILO, a novel dual imaging approach for simultaneous HI-/LOw temporal (Low-/Hi-spatial) resolution imaging for vascular dynamic contrast enhanced cardiovascular magnetic resonance: numerical simulations and feasibility in the carotid arteries. J Cardiovasc Magn Reson. 2013; 15:42.
      View in: PubMed
    15. Arias T, Chen J, Fayad ZA, Fuster V, Hajjar RJ, Chemaly ER. Comparison of echocardiographic measurements of left ventricular volumes to full volume magnetic resonance imaging in normal and diseased rats. J Am Soc Echocardiogr. 2013 Aug; 26(8):910-8.
      View in: PubMed
    16. Barazza A, Blachford C, Even-Or O, Joaquin VA, Briley-Saebo KC, Chen W, Jiang XC, Mulder WJ, Cormode DP, Fayad ZA, Fisher EA. The complex fate in plasma of gadolinium incorporated into high-density lipoproteins used for magnetic imaging of atherosclerotic plaques. Bioconjug Chem. 2013 Jun 19; 24(6):1039-48.
      View in: PubMed
    17. Bini J, Izquierdo-Garcia D, Mateo J, Machac J, Narula J, Fuster V, Fayad ZA. Preclinical evaluation of MR attenuation correction versus CT attenuation correction on a sequential whole-body MR/PET scanner. Invest Radiol. 2013 May; 48(5):313-22.
      View in: PubMed
    18. Millon A, Dickson SD, Klink A, Izquierdo-Garcia D, Bini J, Lancelot E, Ballet S, Robert P, Mateo de Castro J, Corot C, Fayad ZA. Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner. Atherosclerosis. 2013 Jun; 228(2):339-45.
      View in: PubMed
    19. Kamaly N, Fredman G, Subramanian M, Gadde S, Pesic A, Cheung L, Fayad ZA, Langer R, Tabas I, Farokhzad OC. Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles. Proc Natl Acad Sci U S A. 2013 Apr 16; 110(16):6506-11.
      View in: PubMed
    20. Chen W, Cormode DP, Vengrenyuk Y, Herranz B, Feig JE, Klink A, Mulder WJ, Fisher EA, Fayad ZA. Collagen-specific peptide conjugated HDL nanoparticles as MRI contrast agent to evaluate compositional changes in atherosclerotic plaque regression. JACC Cardiovasc Imaging. 2013 Mar; 6(3):373-84.
      View in: PubMed
    21. Mieszawska AJ, Mulder WJ, Fayad ZA, Cormode DP. Multifunctional gold nanoparticles for diagnosis and therapy of disease. Mol Pharm. 2013 Mar 4; 10(3):831-47.
      View in: PubMed
    22. Millon A, Mathevet JL, Boussel L, Faries PL, Fayad ZA, Douek PC, Feugier P. High-resolution magnetic resonance imaging of carotid atherosclerosis identifies vulnerable carotid plaques. J Vasc Surg. 2013 Apr; 57(4):1046-1051.e2.
      View in: PubMed
    23. Cormode DP, Sanchez-Gaytan BL, Mieszawska AJ, Fayad ZA, Mulder WJ. Inorganic nanocrystals as contrast agents in MRI: synthesis, coating and introduction of multifunctionality. NMR Biomed. 2013 Jul; 26(7):766-80.
      View in: PubMed
    24. Duivenvoorden R, Fayad ZA. Safety of CETP inhibition. Curr Opin Lipidol. 2012 Dec; 23(6):518-24.
      View in: PubMed
    25. Mani V, Wong SK, Sawit ST, Calcagno C, Maceda C, Ramachandran S, Fayad ZA, Moline J, McLaughlin MA. Relationship between particulate matter exposure and atherogenic profile in "Ground Zero" workers as shown by dynamic contrast enhanced MR imaging. Int J Cardiovasc Imaging. 2013 Apr; 29(4):827-33.
      View in: PubMed
    26. Hyafil F, Feldman L, Le Guludec D, Fayad ZA. Evaluating efficacy of pharmaceutical interventions in atherosclerosis: role of magnetic resonance imaging and positron emission tomography. Mt Sinai J Med. 2012 Nov-Dec; 79(6):689-704.
      View in: PubMed
    27. Fayad ZA, Greenberg JD, Bucerius J. Subclinical vasculitis as a potential mechanism to explain the heightened cardiovascular risk in rheumatoid arthritis. Circulation. 2012 Nov 20; 126(21):2449-51.
      View in: PubMed
    28. Jarzyna PA, Deddens LH, Kann BH, Ramachandran S, Calcagno C, Chen W, Gianella A, Dijkhuizen RM, Griffioen AW, Fayad ZA, Mulder WJ. Tumor angiogenesis phenotyping by nanoparticle-facilitated magnetic resonance and near-infrared fluorescence molecular imaging. Neoplasia. 2012 Oct; 14(10):964-73.
      View in: PubMed
    29. Rosenbaum D, Millon A, Fayad ZA. Molecular imaging in atherosclerosis: FDG PET. Curr Atheroscler Rep. 2012 Oct; 14(5):429-37.
      View in: PubMed
    30. Cormode DP, Fayad ZA. Letter to the editor re: spectral Hounsfield units--a new radiological concept. Eur Radiol. 2013 Mar; 23(3):640-1.
      View in: PubMed
    31. Elkhawad M, Rudd JH, Sarov-Blat L, Cai G, Wells R, Davies LC, Collier DJ, Marber MS, Choudhury RP, Fayad ZA, Tawakol A, Gleeson FV, Lepore JJ, Davis B, Willette RN, Wilkinson IB, Sprecher DL, Cheriyan J. Effects of p38 mitogen-activated protein kinase inhibition on vascular and systemic inflammation in patients with atherosclerosis. JACC Cardiovasc Imaging. 2012 Sep; 5(9):911-22.
      View in: PubMed
    32. Fleg JL, Stone GW, Fayad ZA, Granada JF, Hatsukami TS, Kolodgie FD, Ohayon J, Pettigrew R, Sabatine MS, Tearney GJ, Waxman S, Domanski MJ, Srinivas PR, Narula J. Detection of high-risk atherosclerotic plaque: report of the NHLBI Working Group on current status and future directions. JACC Cardiovasc Imaging. 2012 Sep; 5(9):941-55.
      View in: PubMed
    33. Vucic E, Calcagno C, Dickson SD, Rudd JH, Hayashi K, Bucerius J, Moshier E, Mounessa JS, Roytman M, Moon MJ, Lin J, Ramachandran S, Tanimoto T, Brown K, Kotsuma M, Tsimikas S, Fisher EA, Nicolay K, Fuster V, Fayad ZA. Regression of inflammation in atherosclerosis by the LXR agonist R211945: a noninvasive assessment and comparison with atorvastatin. JACC Cardiovasc Imaging. 2012 Aug; 5(8):819-28.
      View in: PubMed
    34. Galper MW, Saung MT, Fuster V, Roessl E, Thran A, Proksa R, Fayad ZA, Cormode DP. Effect of computed tomography scanning parameters on gold nanoparticle and iodine contrast. Invest Radiol. 2012 Aug; 47(8):475-81.
      View in: PubMed
    35. Yankeelov TE, Peterson TE, Abramson RG, Izquierdo-Garcia D, Garcia-Izquierdo D, Arlinghaus LR, Li X, Atuegwu NC, Catana C, Manning HC, Fayad ZA, Gore JC. Simultaneous PET-MRI in oncology: a solution looking for a problem? Magn Reson Imaging. 2012 Nov; 30(9):1342-56.
      View in: PubMed
    36. Purushothaman KR, Purushothaman M, Levy AP, Lento PA, Evrard S, Kovacic JC, Briley-Saebo KC, Tsimikas S, Witztum JL, Krishnan P, Kini A, Fayad ZA, Fuster V, Sharma SK, Moreno PR. Increased expression of oxidation-specific epitopes and apoptosis are associated with haptoglobin genotype: possible implications for plaque progression in human atherosclerosis. J Am Coll Cardiol. 2012 Jul 10; 60(2):112-9.
      View in: PubMed
    37. Kim Y, Lee Chung B, Ma M, Mulder WJ, Fayad ZA, Farokhzad OC, Langer R. Mass production and size control of lipid-polymer hybrid nanoparticles through controlled microvortices. Nano Lett. 2012 Jul 11; 12(7):3587-91.
      View in: PubMed
    38. Momiyama Y, Ohmori R, Fayad ZA, Tanaka N, Kato R, Taniguchi H, Nagata M, Ohsuzu F. Association between kidney dysfuction and the severity of coronary and aortic atherosclerosis. Atherosclerosis. 2012 Aug; 223(2):523-6.
      View in: PubMed
    39. Bucerius J, Mani V, Moncrieff C, Rudd JH, Machac J, Fuster V, Farkouh ME, Fayad ZA. Impact of noninsulin-dependent type 2 diabetes on carotid wall 18F-fluorodeoxyglucose positron emission tomography uptake. J Am Coll Cardiol. 2012 Jun 5; 59(23):2080-8.
      View in: PubMed
    40. Mieszawska AJ, Gianella A, Cormode DP, Zhao Y, Meijerink A, Langer R, Farokhzad OC, Fayad ZA, Mulder WJ. Engineering of lipid-coated PLGA nanoparticles with a tunable payload of diagnostically active nanocrystals for medical imaging. Chem Commun (Camb). 2012 Jun 14; 48(47):5835-7.
      View in: PubMed
    41. Bucerius J, Manka C, Schmaljohann J, Mani V, Gündisch D, Rudd JH, Bippus R, Mottaghy FM, Wüllner U, Fayad ZA, Biersack HJ. Feasibility of [18F]-2-Fluoro-A85380-PET imaging of human vascular nicotinic acetylcholine receptors in vivo. JACC Cardiovasc Imaging. 2012 May; 5(5):528-36.
      View in: PubMed
    42. Rosenson RS, Brewer HB, Davidson WS, Fayad ZA, Fuster V, Goldstein J, Hellerstein M, Jiang XC, Phillips MC, Rader DJ, Remaley AT, Rothblat GH, Tall AR, Yvan-Charvet L. Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. Circulation. 2012 Apr 17; 125(15):1905-19.
      View in: PubMed
    43. Berker Y, Franke J, Salomon A, Palmowski M, Donker HC, Temur Y, Mottaghy FM, Kuhl C, Izquierdo-Garcia D, Fayad ZA, Kiessling F, Schulz V. MRI-based attenuation correction for hybrid PET/MRI systems: a 4-class tissue segmentation technique using a combined ultrashort-echo-time/Dixon MRI sequence. J Nucl Med. 2012 May; 53(5):796-804.
      View in: PubMed
    44. Momiyama Y, Ohmori R, Fayad ZA, Tanaka N, Kato R, Taniguchi H, Nagata M, Ohsuzu F. The LDL-cholesterol to HDL-cholesterol ratio and the severity of coronary and aortic atherosclerosis. Atherosclerosis. 2012 Jun; 222(2):577-80.
      View in: PubMed
    45. Momiyama Y, Ohmori R, Fayad ZA, Tanaka N, Kato R, Taniguchi H, Nagata M, Ohsuzu F. Associations between serum lipoprotein(a) levels and the severity of coronary and aortic atherosclerosis. Atherosclerosis. 2012 May; 222(1):241-4.
      View in: PubMed
    46. Briley-Saebo KC, Nguyen TH, Saeboe AM, Cho YS, Ryu SK, Volkova ER, Volkava E, Dickson S, Leibundgut G, Wiesner P, Weisner P, Green S, Casanada F, Miller YI, Shaw W, Witztum JL, Fayad ZA, Tsimikas S. In vivo detection of oxidation-specific epitopes in atherosclerotic lesions using biocompatible manganese molecular magnetic imaging probes. J Am Coll Cardiol. 2012 Feb 7; 59(6):616-26.
      View in: PubMed
    47. Myers KS, Rudd JH, Hailman EP, Bolognese JA, Burke J, Pinto CA, Klimas M, Hargreaves R, Dansky HM, Fayad ZA. Correlation between arterial FDG uptake and biomarkers in peripheral artery disease. JACC Cardiovasc Imaging. 2012 Jan; 5(1):38-45.
      View in: PubMed
    48. Lobatto ME, Calcagno C, Metselaar JM, Storm G, Stroes ES, Fayad ZA, Mulder WJ. Imaging the efficacy of anti-inflammatory liposomes in a rabbit model of atherosclerosis by non-invasive imaging. Methods Enzymol. 2012; 508:211-28.
      View in: PubMed
    49. Klink A, Heynens J, Herranz B, Lobatto ME, Arias T, Sanders HM, Strijkers GJ, Merkx M, Nicolay K, Fuster V, Tedgui A, Mallat Z, Mulder WJ, Fayad ZA. In vivo characterization of a new abdominal aortic aneurysm mouse model with conventional and molecular magnetic resonance imaging. J Am Coll Cardiol. 2011 Dec 6; 58(24):2522-30.
      View in: PubMed
    50. Buettner C, Rudd JH, Fayad ZA. Determinants of FDG uptake in atherosclerosis. JACC Cardiovasc Imaging. 2011 Dec; 4(12):1302-4.
      View in: PubMed
    51. Bucerius J, Duivenvoorden R, Mani V, Moncrieff C, Rudd JH, Calcagno C, Machac J, Fuster V, Farkouh ME, Fayad ZA. Prevalence and risk factors of carotid vessel wall inflammation in coronary artery disease patients: FDG-PET and CT imaging study. JACC Cardiovasc Imaging. 2011 Nov; 4(11):1195-205.
      View in: PubMed
    52. Lobatto ME, Fuster V, Fayad ZA, Mulder WJ. Perspectives and opportunities for nanomedicine in the management of atherosclerosis. Nat Rev Drug Discov. 2011 Nov; 10(11):835-52.
      View in: PubMed
    53. Furer V, Fayad ZA, Mani V, Calcagno C, Farkouh ME, Greenberg JD. Noninvasive cardiovascular imaging in rheumatoid arthritis: current modalities and the emerging role of magnetic resonance and positron emission tomography imaging. Semin Arthritis Rheum. 2012 Apr; 41(5):676-88.
      View in: PubMed
    54. Vucic E, Dickson SD, Calcagno C, Rudd JH, Moshier E, Hayashi K, Mounessa JS, Roytman M, Moon MJ, Lin J, Tsimikas S, Fisher EA, Nicolay K, Fuster V, Fayad ZA. Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging. JACC Cardiovasc Imaging. 2011 Oct; 4(10):1100-9.
      View in: PubMed
    55. Dikaios N, Izquierdo-Garcia D, Graves MJ, Mani V, Fayad ZA, Fryer TD. MRI-based motion correction of thoracic PET: initial comparison of acquisition protocols and correction strategies suitable for simultaneous PET/MRI systems. Eur Radiol. 2012 Feb; 22(2):439-46.
      View in: PubMed
    56. Fayad ZA, Mani V, Woodward M, Kallend D, Abt M, Burgess T, Fuster V, Ballantyne CM, Stein EA, Tardif JC, Rudd JH, Farkouh ME, Tawakol A. Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial. Lancet. 2011 Oct 29; 378(9802):1547-59.
      View in: PubMed
    57. Marwick TH, Chandrashekhar Y, Achenbach S, Dilsizian V, Fayad ZA, Finn AV, Hundley WG, Kern MJ, Kramer CM, Sengupta PP, Shaw LJ, Zoghbi WA, Narula J. Bibliographic metrics at JACC: cardiovascular imaging an opportunity for audit and reflection. JACC Cardiovasc Imaging. 2011 Sep; 4(9):1050-1.
      View in: PubMed
    58. Kramer CM, Mani V, Fayad ZA. MR imaging-verified plaque delipidation with lipid-lowering therapy important questions remain. JACC Cardiovasc Imaging. 2011 Sep; 4(9):987-9.
      View in: PubMed
    59. Fayad ZA, Mani V, Fuster V. The time has come for clinical cardiovascular trials with plaque characterization as an endpoint. Eur Heart J. 2012 Jan; 33(2):160-1.
      View in: PubMed
    60. Fayad ZA, Mani V, Woodward M, Kallend D, Bansilal S, Pozza J, Burgess T, Fuster V, Rudd JH, Tawakol A, Farkouh ME. Rationale and design of dal-PLAQUE: a study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography. Am Heart J. 2011 Aug; 162(2):214-221.e2.
      View in: PubMed
    61. Duivenvoorden R, Fayad ZA. Utility of atherosclerosis imaging in the evaluation of high-density lipoprotein-raising therapies. Curr Atheroscler Rep. 2011 Jun; 13(3):277-84.
      View in: PubMed
    62. Gianella A, Jarzyna PA, Mani V, Ramachandran S, Calcagno C, Tang J, Kann B, Dijk WJ, Thijssen VL, Griffioen AW, Storm G, Fayad ZA, Mulder WJ. Multifunctional nanoemulsion platform for imaging guided therapy evaluated in experimental cancer. ACS Nano. 2011 Jun 28; 5(6):4422-33.
      View in: PubMed
    63. Buxton DB, Antman M, Danthi N, Dilsizian V, Fayad ZA, Garcia MJ, Jaff MR, Klimas M, Libby P, Nahrendorf M, Sinusas AJ, Wickline SA, Wu JC, Bonow RO, Weissleder R. Report of the National Heart, Lung, and Blood Institute working group on the translation of cardiovascular molecular imaging. Circulation. 2011 May 17; 123(19):2157-63.
      View in: PubMed
    64. Zaidi H, Ojha N, Morich M, Griesmer J, Hu Z, Maniawski P, Ratib O, Izquierdo-Garcia D, Fayad ZA, Shao L. Design and performance evaluation of a whole-body Ingenuity TF PET-MRI system. Phys Med Biol. 2011 May 21; 56(10):3091-106.
      View in: PubMed
    65. Cormode DP, Skajaa GO, Delshad A, Parker N, Jarzyna PA, Calcagno C, Galper MW, Skajaa T, Briley-Saebo KC, Bell HM, Gordon RE, Fayad ZA, Woo SL, Mulder WJ. A versatile and tunable coating strategy allows control of nanocrystal delivery to cell types in the liver. Bioconjug Chem. 2011 Mar 16; 22(3):353-61.
      View in: PubMed
    66. Klink A, Hyafil F, Rudd J, Faries P, Fuster V, Mallat Z, Meilhac O, Mulder WJ, Michel JB, Ramirez F, Storm G, Thompson R, Turnbull IC, Egido J, Martín-Ventura JL, Zaragoza C, Letourneur D, Fayad ZA. Diagnostic and therapeutic strategies for small abdominal aortic aneurysms. Nat Rev Cardiol. 2011 Jun; 8(6):338-47.
      View in: PubMed
    67. Owen DR, Lindsay AC, Choudhury RP, Fayad ZA. Imaging of atherosclerosis. Annu Rev Med. 2011; 62:25-40.
      View in: PubMed
    68. Skajaa T, Cormode DP, Jarzyna PA, Delshad A, Blachford C, Barazza A, Fisher EA, Gordon RE, Fayad ZA, Mulder WJ. The biological properties of iron oxide core high-density lipoprotein in experimental atherosclerosis. Biomaterials. 2011 Jan; 32(1):206-13.
      View in: PubMed
    69. Cormode DP, Mulder WJ, Fayad ZA. Science to practice: versatile method to track transplanted encapsulated islet cells with multiple imaging modalities. Radiology. 2011 Jan; 258(1):1-2.
      View in: PubMed
    70. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, Foster E, Hlatky MA, Hodgson JM, Kushner FG, Lauer MS, Shaw LJ, Smith SC, Taylor AJ, Weintraub WS, Wenger NK, Jacobs AK, Smith SC, Anderson JL, Albert N, Buller CE, Creager MA, Ettinger SM, Guyton RA, Halperin JL, Hochman JS, Kushner FG, Nishimura R, Ohman EM, Page RL, Stevenson WG, Tarkington LG, Yancy CW. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2010 Dec 14; 56(25):e50-103.
      View in: PubMed
    71. Duivenvoorden R, Fayad ZA. Molecular imaging: Measuring myocardial fatty acid metabolism with BMIPP SPECT. Nat Rev Cardiol. 2010 Dec; 7(12):672-3.
      View in: PubMed
    72. Hyafil F, Vucic E, Cornily JC, Sharma R, Amirbekian V, Blackwell F, Lancelot E, Corot C, Fuster V, Galis ZS, Feldman LJ, Fayad ZA. Monitoring of arterial wall remodelling in atherosclerotic rabbits with a magnetic resonance imaging contrast agent binding to matrix metalloproteinases. Eur Heart J. 2011 Jun; 32(12):1561-71.
      View in: PubMed
    73. Briley-Saebo KC, Cho YS, Shaw PX, Ryu SK, Mani V, Dickson S, Izadmehr E, Green S, Fayad ZA, Tsimikas S. Targeted iron oxide particles for in vivo magnetic resonance detection of atherosclerotic lesions with antibodies directed to oxidation-specific epitopes. J Am Coll Cardiol. 2011 Jan 18; 57(3):337-47.
      View in: PubMed
    74. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, Foster E, Hlatky MA, Hodgson JM, Kushner FG, Lauer MS, Shaw LJ, Smith SC, Taylor AJ, Weintraub WS, Wenger NK, Jacobs AK. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2010 Dec 21; 122(25):2748-64.
      View in: PubMed
    75. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, Foster E, Hlatky MA, Hodgson JM, Kushner FG, Lauer MS, Shaw LJ, Smith SC, Taylor AJ, Weintraub WS, Wenger NK, Jacobs AK. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2010 Dec 21; 122(25):e584-636.
      View in: PubMed
    76. Lobatto ME, Fayad ZA, Silvera S, Vucic E, Calcagno C, Mani V, Dickson SD, Nicolay K, Banciu M, Schiffelers RM, Metselaar JM, van Bloois L, Wu HS, Fallon JT, Rudd JH, Fuster V, Fisher EA, Storm G, Mulder WJ. Multimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosis. Mol Pharm. 2010 Dec 6; 7(6):2020-9.
      View in: PubMed
    77. Briley-Saebo KC, Leboeuf M, Dickson S, Mani V, Fayad ZA, Palucka AK, Banchereau J, Merad M. Longitudinal tracking of human dendritic cells in murine models using magnetic resonance imaging. Magn Reson Med. 2010 Nov; 64(5):1510-9.
      View in: PubMed
    78. van Tilborg GA, Vucic E, Strijkers GJ, Cormode DP, Mani V, Skajaa T, Reutelingsperger CP, Fayad ZA, Mulder WJ, Nicolay K. Annexin A5-functionalized bimodal nanoparticles for MRI and fluorescence imaging of atherosclerotic plaques. Bioconjug Chem. 2010 Oct 20; 21(10):1794-803.
      View in: PubMed
    79. Cormode DP, Roessl E, Thran A, Skajaa T, Gordon RE, Schlomka JP, Fuster V, Fisher EA, Mulder WJ, Proksa R, Fayad ZA. Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles. Radiology. 2010 Sep; 256(3):774-82.
      View in: PubMed
    80. van Schooneveld MM, Cormode DP, Koole R, van Wijngaarden JT, Calcagno C, Skajaa T, Hilhorst J, 't Hart DC, Fayad ZA, Mulder WJ, Meijerink A. A fluorescent, paramagnetic and PEGylated gold/silica nanoparticle for MRI, CT and fluorescence imaging. Contrast Media Mol Imaging. 2010 Jul-Aug; 5(4):231-6.
      View in: PubMed
    81. Calcagno C, Vucic E, Mani V, Goldschlager G, Fayad ZA. Reproducibility of black blood dynamic contrast-enhanced magnetic resonance imaging in aortic plaques of atherosclerotic rabbits. J Magn Reson Imaging. 2010 Jul; 32(1):191-8.
      View in: PubMed
    82. Rudd JH, Narula J, Strauss HW, Virmani R, Machac J, Klimas M, Tahara N, Fuster V, Warburton EA, Fayad ZA, Tawakol AA. Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? J Am Coll Cardiol. 2010 Jun 8; 55(23):2527-35.
      View in: PubMed
    83. Calcagno C, Mani V, Ramachandran S, Fayad ZA. Dynamic contrast enhanced (DCE) magnetic resonance imaging (MRI) of atherosclerotic plaque angiogenesis. Angiogenesis. 2010 Jun; 13(2):87-99.
      View in: PubMed
    84. Sadeghi MM, Glover DK, Lanza GM, Fayad ZA, Johnson LL. Imaging atherosclerosis and vulnerable plaque. J Nucl Med. 2010 May 1; 51 Suppl 1:51S-65S.
      View in: PubMed
    85. Hayashi K, Mani V, Nemade A, Aguiar S, Postley JE, Fuster V, Fayad ZA. Variations in atherosclerosis and remodeling patterns in aorta and carotids. J Cardiovasc Magn Reson. 2010; 12:10.
      View in: PubMed
    86. Jarzyna PA, Gianella A, Skajaa T, Knudsen G, Deddens LH, Cormode DP, Fayad ZA, Mulder WJ. Multifunctional imaging nanoprobes. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010 Mar-Apr; 2(2):138-50.
      View in: PubMed
    87. Klink A, Lancelot E, Ballet S, Vucic E, Fabre JE, Gonzalez W, Medina C, Corot C, Mulder WJ, Mallat Z, Fayad ZA. Magnetic resonance molecular imaging of thrombosis in an arachidonic acid mouse model using an activated platelet targeted probe. Arterioscler Thromb Vasc Biol. 2010 Mar; 30(3):403-10.
      View in: PubMed
    88. Momiyama Y, Ohmori R, Fayad ZA, Kihara T, Tanaka N, Kato R, Taniguchi H, Nagata M, Nakamura H, Ohsuzu F. Associations between plasma C-reactive protein levels and the severities of coronary and aortic atherosclerosis. J Atheroscler Thromb. 2010 May; 17(5):460-7.
      View in: PubMed
    89. Underhill HR, Hatsukami TS, Fayad ZA, Fuster V, Yuan C. MRI of carotid atherosclerosis: clinical implications and future directions. Nat Rev Cardiol. 2010 Mar; 7(3):165-73.
      View in: PubMed
    90. Chen W, Jarzyna PA, van Tilborg GA, Nguyen VA, Cormode DP, Klink A, Griffioen AW, Randolph GJ, Fisher EA, Mulder WJ, Fayad ZA. RGD peptide functionalized and reconstituted high-density lipoprotein nanoparticles as a versatile and multimodal tumor targeting molecular imaging probe. FASEB J. 2010 Jun; 24(6):1689-99.
      View in: PubMed
    91. Momiyama Y, Ohmori R, Fayad ZA, Kihara T, Tanaka N, Kato R, Taniguchi H, Nagata M, Nakamura H, Ohsuzu F. Associations between plasma osteopontin levels and the severities of coronary and aortic atherosclerosis. Atherosclerosis. 2010 Jun; 210(2):668-70.
      View in: PubMed
    92. Hayashi K, Mani V, Nemade A, Silvera S, Fayad ZA. Comparison of 3D-diffusion-prepared segmented steady-state free precession and 2D fast spin echo imaging of femoral artery atherosclerosis. Int J Cardiovasc Imaging. 2010 Mar; 26(3):309-21.
      View in: PubMed
    93. Adler ED, Chen VC, Bystrup A, Kaplan AD, Giovannone S, Briley-Saebo K, Young W, Kattman S, Mani V, Laflamme M, Zhu WZ, Fayad Z, Keller G. The cardiomyocyte lineage is critical for optimization of stem cell therapy in a mouse model of myocardial infarction. FASEB J. 2010 Apr; 24(4):1073-81.
      View in: PubMed
    94. Cormode DP, Jarzyna PA, Mulder WJ, Fayad ZA. Modified natural nanoparticles as contrast agents for medical imaging. Adv Drug Deliv Rev. 2010 Mar 8; 62(3):329-38.
      View in: PubMed
    95. Beilvert A, Cormode DP, Chaubet F, Briley-Saebo KC, Mani V, Mulder WJ, Vucic E, Toussaint JF, Letourneur D, Fayad ZA. Tyrosine polyethylene glycol (PEG)-micelle magnetic resonance contrast agent for the detection of lipid rich areas in atherosclerotic plaque. Magn Reson Med. 2009 Nov; 62(5):1195-201.
      View in: PubMed
    96. Skajaa T, Cormode DP, Falk E, Mulder WJ, Fisher EA, Fayad ZA. High-density lipoprotein-based contrast agents for multimodal imaging of atherosclerosis. Arterioscler Thromb Vasc Biol. 2010 Feb; 30(2):169-76.
      View in: PubMed
    97. Jarzyna PA, Skajaa T, Gianella A, Cormode DP, Samber DD, Dickson SD, Chen W, Griffioen AW, Fayad ZA, Mulder WJ. Iron oxide core oil-in-water emulsions as a multifunctional nanoparticle platform for tumor targeting and imaging. Biomaterials. 2009 Dec; 30(36):6947-54.
      View in: PubMed
    98. Adler ED, Bystrup A, Briley-Saebo KC, Mani V, Young W, Giovanonne S, Altman P, Kattman SJ, Frank JA, Weinmann HJ, Keller GM, Fayad ZA. In vivo detection of embryonic stem cell-derived cardiovascular progenitor cells using Cy3-labeled Gadofluorine M in murine myocardium. JACC Cardiovasc Imaging. 2009 Sep; 2(9):1114-22.
      View in: PubMed
    99. Rudd JH, Elkhawad M, Fayad ZA. Vascular imaging with 18F-FDG PET/CT: optimal 18F-FDG circulation time? J Nucl Med. 2009 Sep; 50(9):1560; author reply 1560-1.
      View in: PubMed
    100. Sirol M, Moreno PR, Purushothaman KR, Vucic E, Amirbekian V, Weinmann HJ, Muntner P, Fuster V, Fayad ZA. Increased neovascularization in advanced lipid-rich atherosclerotic lesions detected by gadofluorine-M-enhanced MRI: implications for plaque vulnerability. Circ Cardiovasc Imaging. 2009 Sep; 2(5):391-6.
      View in: PubMed
    101. Mulder WJ, Strijkers GJ, van Tilborg GA, Cormode DP, Fayad ZA, Nicolay K. Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imaging. Acc Chem Res. 2009 Jul 21; 42(7):904-14.
      View in: PubMed
    102. Fayad ZA. Cardiovascular molecular imaging. Arterioscler Thromb Vasc Biol. 2009 Jul; 29(7):981-2.
      View in: PubMed
    103. Fayad ZA, Razzouk L, Briley-Saebo KC, Mani V. Iron oxide magnetic resonance imaging for atherosclerosis therapeutic evaluation: still "rusty?". J Am Coll Cardiol. 2009 Jun 2; 53(22):2051-2.
      View in: PubMed
    104. Duivenvoorden R, de Groot E, Afzali H, Vanbavel ET, de Boer OJ, Laméris JS, Fayad ZA, Stroes ES, Kastelein JJ, Nederveen AJ. Comparison of in vivo carotid 3.0-T magnetic resonance to B-mode ultrasound imaging and histology in a porcine model. JACC Cardiovasc Imaging. 2009 Jun; 2(6):744-50.
      View in: PubMed
    105. Cormode DP, Chandrasekar R, Delshad A, Briley-Saebo KC, Calcagno C, Barazza A, Mulder WJ, Fisher EA, Fayad ZA. Comparison of synthetic high density lipoprotein (HDL) contrast agents for MR imaging of atherosclerosis. Bioconjug Chem. 2009 May 20; 20(5):937-43.
      View in: PubMed
    106. Floris-Moore M, Fayad ZA, Berman JW, Mani V, Schoenbaum EE, Klein RS, Weinshelbaum KB, Fuster V, Howard AA, Lo Y, Schecter AD. Association of HIV viral load with monocyte chemoattractant protein-1 and atherosclerosis burden measured by magnetic resonance imaging. AIDS. 2009 May 15; 23(8):941-9.
      View in: PubMed
    107. Hyafil F, Cornily JC, Rudd JH, Machac J, Feldman LJ, Fayad ZA. Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology. J Nucl Med. 2009 Jun; 50(6):959-65.
      View in: PubMed
    108. Briley-Saebo KC, Geninatti-Crich S, Cormode DP, Barazza A, Mulder WJ, Chen W, Giovenzana GB, Fisher EA, Aime S, Fayad ZA. High-relaxivity gadolinium-modified high-density lipoproteins as magnetic resonance imaging contrast agents. J Phys Chem B. 2009 May 7; 113(18):6283-9.
      View in: PubMed
    109. Lipinski MJ, Frias JC, Amirbekian V, Briley-Saebo KC, Mani V, Samber D, Abbate A, Aguinaldo JG, Massey D, Fuster V, Vetrovec GW, Fayad ZA. Macrophage-specific lipid-based nanoparticles improve cardiac magnetic resonance detection and characterization of human atherosclerosis. JACC Cardiovasc Imaging. 2009 May; 2(5):637-47.
      View in: PubMed
    110. Amirbekian V, Aguinaldo JG, Amirbekian S, Hyafil F, Vucic E, Sirol M, Weinreb DB, Le Greneur S, Lancelot E, Corot C, Fisher EA, Galis ZS, Fayad ZA. Atherosclerosis and matrix metalloproteinases: experimental molecular MR imaging in vivo. Radiology. 2009 May; 251(2):429-38.
      View in: PubMed
    111. Li D, Fayad ZA, Bluemke DA. Can contrast-enhanced cardiac magnetic resonance assess inflammation of the coronary wall? JACC Cardiovasc Imaging. 2009 May; 2(5):589-91.
      View in: PubMed
    112. Silvera SS, Aidi HE, Rudd JH, Mani V, Yang L, Farkouh M, Fuster V, Fayad ZA. Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries. Atherosclerosis. 2009 Nov; 207(1):139-43.
      View in: PubMed
    113. Mani V, Muntner P, Gidding SS, Aguiar SH, El Aidi H, Weinshelbaum KB, Taniguchi H, van der Geest R, Reiber JH, Bansilal S, Farkouh M, Fuster V, Postley JE, Woodward M, Fayad ZA. Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular events. J Cardiovasc Magn Reson. 2009; 11:10.
      View in: PubMed
    114. Yonemura A, Momiyama Y, Fayad ZA, Ayaori M, Ohmori R, Kihara T, Tanaka N, Nakaya K, Ogura M, Taniguchi H, Kusuhara M, Nagata M, Nakamura H, Tamai S, Ohsuzu F. Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques: a 2-year follow-up by noninvasive MRI. Eur J Cardiovasc Prev Rehabil. 2009 Apr; 16(2):222-8.
      View in: PubMed
    115. Rudd JH, Hyafil F, Fayad ZA. Inflammation imaging in atherosclerosis. Arterioscler Thromb Vasc Biol. 2009 Jul; 29(7):1009-16.
      View in: PubMed
    116. El Aidi H, Mani V, Weinshelbaum KB, Aguiar SH, Taniguchi H, Postley JE, Samber DD, Cohen EI, Stern J, van der Geest RJ, Reiber JH, Woodward M, Fuster V, Gidding SS, Fayad ZA. Cross-sectional, prospective study of MRI reproducibility in the assessment of plaque burden of the carotid arteries and aorta. Nat Clin Pract Cardiovasc Med. 2009 Mar; 6(3):219-28.
      View in: PubMed
    117. Rudd JH, Myers KS, Bansilal S, Machac J, Woodward M, Fuster V, Farkouh ME, Fayad ZA. Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study. Circ Cardiovasc Imaging. 2009 Mar; 2(2):107-15.
      View in: PubMed
    118. Vucic E, Sanders HM, Arena F, Terreno E, Aime S, Nicolay K, Leupold E, Dathe M, Sommerdijk NA, Fayad ZA, Mulder WJ. Well-defined, multifunctional nanostructures of a paramagnetic lipid and a lipopeptide for macrophage imaging. J Am Chem Soc. 2009 Jan 21; 131(2):406-7.
      View in: PubMed
    119. Nahrendorf M, Sosnovik DE, French BA, Swirski FK, Bengel F, Sadeghi MM, Lindner JR, Wu JC, Kraitchman DL, Fayad ZA, Sinusas AJ. Multimodality cardiovascular molecular imaging, Part II. Circ Cardiovasc Imaging. 2009 Jan; 2(1):56-70.
      View in: PubMed
    120. Mulder WJ, Castermans K, van Beijnum JR, Oude Egbrink MG, Chin PT, Fayad ZA, Löwik CW, Kaijzel EL, Que I, Storm G, Strijkers GJ, Griffioen AW, Nicolay K. Molecular imaging of tumor angiogenesis using alphavbeta3-integrin targeted multimodal quantum dots. Angiogenesis. 2009; 12(1):17-24.
      View in: PubMed
    121. Cormode DP, Skajaa T, Fayad ZA, Mulder WJ. Nanotechnology in medical imaging: probe design and applications. Arterioscler Thromb Vasc Biol. 2009 Jul; 29(7):992-1000.
      View in: PubMed
    122. Koole R, van Schooneveld MM, Hilhorst J, Castermans K, Cormode DP, Strijkers GJ, de Mello Donegá C, Vanmaekelbergh D, Griffioen AW, Nicolay K, Fayad ZA, Meijerink A, Mulder WJ. Paramagnetic lipid-coated silica nanoparticles with a fluorescent quantum dot core: a new contrast agent platform for multimodality imaging. Bioconjug Chem. 2008 Dec; 19(12):2471-9.
      View in: PubMed
    123. Worthley SG, Zhang ZY, Machac J, Helft G, Tang C, Liew GY, Zaman AG, Worthley MI, Fayad ZA, Buchsbaum MS, Fuster V, Badimon JJ. In vivo non-invasive serial monitoring of FDG-PET progression and regression in a rabbit model of atherosclerosis. Int J Cardiovasc Imaging. 2009 Mar; 25(3):251-7.
      View in: PubMed
    124. Sinusas AJ, Bengel F, Nahrendorf M, Epstein FH, Wu JC, Villanueva FS, Fayad ZA, Gropler RJ. Multimodality cardiovascular molecular imaging, part I. Circ Cardiovasc Imaging. 2008 Nov; 1(3):244-56.
      View in: PubMed
    125. Fayad ZA, Vucic E. "Feeling the RAGE" in the atherosclerotic vessel wall. Circ Cardiovasc Imaging. 2008 Nov; 1(3):178-9.
      View in: PubMed
    126. Chen W, Vucic E, Leupold E, Mulder WJ, Cormode DP, Briley-Saebo KC, Barazza A, Fisher EA, Dathe M, Fayad ZA. Incorporation of an apoE-derived lipopeptide in high-density lipoprotein MRI contrast agents for enhanced imaging of macrophages in atherosclerosis. Contrast Media Mol Imaging. 2008 Nov-Dec; 3(6):233-42.
      View in: PubMed
    127. Cormode DP, Skajaa T, van Schooneveld MM, Koole R, Jarzyna P, Lobatto ME, Calcagno C, Barazza A, Gordon RE, Zanzonico P, Fisher EA, Fayad ZA, Mulder WJ. Nanocrystal core high-density lipoproteins: a multimodality contrast agent platform. Nano Lett. 2008 Nov; 8(11):3715-23.
      View in: PubMed
    128. Cormode DP, Briley-Saebo KC, Mulder WJ, Aguinaldo JG, Barazza A, Ma Y, Fisher EA, Fayad ZA. An ApoA-I mimetic peptide high-density-lipoprotein-based MRI contrast agent for atherosclerotic plaque composition detection. Small. 2008 Sep; 4(9):1437-44.
      View in: PubMed
    129. Lipinski MJ, Briley-Saebo KC, Mani V, Fayad ZA. "Positive contrast" inversion-recovery with ON[corrected]-resonant water suppression magnetic resonance imaging: a change for the better? J Am Coll Cardiol. 2008 Aug 5; 52(6):492-4.
      View in: PubMed
    130. Fayad ZA, Fuster V. Prologue: relevance of molecular imaging in clinical medicine. Nat Clin Pract Cardiovasc Med. 2008 Aug; 5 Suppl 2:S1.
      View in: PubMed
    131. Rudd JH, Fayad ZA. Imaging atherosclerotic plaque inflammation. Nat Clin Pract Cardiovasc Med. 2008 Aug; 5 Suppl 2:S11-7.
      View in: PubMed
    132. Mulder WJ, Cormode DP, Hak S, Lobatto ME, Silvera S, Fayad ZA. Multimodality nanotracers for cardiovascular applications. Nat Clin Pract Cardiovasc Med. 2008 Aug; 5 Suppl 2:S103-11.
      View in: PubMed
    133. van Schooneveld MM, Vucic E, Koole R, Zhou Y, Stocks J, Cormode DP, Tang CY, Gordon RE, Nicolay K, Meijerink A, Fayad ZA, Mulder WJ. Improved biocompatibility and pharmacokinetics of silica nanoparticles by means of a lipid coating: a multimodality investigation. Nano Lett. 2008 Aug; 8(8):2517-25.
      View in: PubMed
    134. Mani V, Adler E, Briley-Saebo KC, Bystrup A, Fuster V, Keller G, Fayad ZA. Serial in vivo positive contrast MRI of iron oxide-labeled embryonic stem cell-derived cardiac precursor cells in a mouse model of myocardial infarction. Magn Reson Med. 2008 Jul; 60(1):73-81.
      View in: PubMed
    135. Briley-Saebo KC, Shaw PX, Mulder WJ, Choi SH, Vucic E, Aguinaldo JG, Witztum JL, Fuster V, Tsimikas S, Fayad ZA. Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes. Circulation. 2008 Jun 24; 117(25):3206-15.
      View in: PubMed
    136. Cornily JC, Hyafil F, Calcagno C, Briley-Saebo KC, Tunstead J, Aguinaldo JG, Mani V, Lorusso V, Cavagna FM, Fayad ZA. Evaluation of neovessels in atherosclerotic plaques of rabbits using an albumin-binding intravascular contrast agent and MRI. J Magn Reson Imaging. 2008 Jun; 27(6):1406-11.
      View in: PubMed
    137. Rudd JH, Myers KS, Bansilal S, Machac J, Pinto CA, Tong C, Rafique A, Hargeaves R, Farkouh M, Fuster V, Fayad ZA. Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med. 2008 Jun; 49(6):871-8.
      View in: PubMed
    138. Calcagno C, Cornily JC, Hyafil F, Rudd JH, Briley-Saebo KC, Mani V, Goldschlager G, Machac J, Fuster V, Fayad ZA. Detection of neovessels in atherosclerotic plaques of rabbits using dynamic contrast enhanced MRI and 18F-FDG PET. Arterioscler Thromb Vasc Biol. 2008 Jul; 28(7):1311-7.
      View in: PubMed
    139. Mulder WJ, Fayad ZA. Nanomedicine captures cardiovascular disease. Arterioscler Thromb Vasc Biol. 2008 May; 28(5):801-2.
      View in: PubMed
    140. Briley-Saebo KC, Mani V, Hyafil F, Cornily JC, Fayad ZA. Fractionated Feridex and positive contrast: in vivo MR imaging of atherosclerosis. Magn Reson Med. 2008 Apr; 59(4):721-30.
      View in: PubMed
    141. Worthley SG, Helft G, Corti R, Worthley MI, Chew DP, Fayad ZA, Zaman AG, Fallon JT, Fuster V, Badimon JJ. Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis. Pathophysiol Haemost Thromb. 2007; 36(1):9-17.
      View in: PubMed
    142. Sanz J, Fayad ZA. Imaging of atherosclerotic cardiovascular disease. Nature. 2008 Feb 21; 451(7181):953-7.
      View in: PubMed
    143. Lancelot E, Amirbekian V, Brigger I, Raynaud JS, Ballet S, David C, Rousseaux O, Le Greneur S, Port M, Lijnen HR, Bruneval P, Michel JB, Ouimet T, Roques B, Amirbekian S, Hyafil F, Vucic E, Aguinaldo JG, Corot C, Fayad ZA. Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach. Arterioscler Thromb Vasc Biol. 2008 Mar; 28(3):425-32.
      View in: PubMed
    144. Budoff MJ, Achenbach S, Berman DS, Fayad ZA, Poon M, Taylor AJ, Uretsky BF, Williams KA. Task force 13: training in advanced cardiovascular imaging (computed tomography) endorsed by the American Society of Nuclear Cardiology, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, and Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2008 Jan 22; 51(3):409-14.
      View in: PubMed
    145. Budoff MJ, Achenbach S, Berman DS, Fayad ZA, Poon M, Taylor AJ, Uretsky BF, Williams KA. Task force 13: training in advanced cardiovascular imaging (computed tomography). J Cardiovasc Comput Tomogr. 2008 Mar-Apr; 2(2):130-5.
      View in: PubMed
    146. Hyafil F, Cornily JC, Fayad ZA. [Detecting patients at risk of developing an acute myocardial infarction: dream or reality?]. Med Sci (Paris). 2007 Dec; 23(12):1094-6.
      View in: PubMed
    147. Mulder WJ, Strijkers GJ, Briley-Saboe KC, Frias JC, Aguinaldo JG, Vucic E, Amirbekian V, Tang C, Chin PT, Nicolay K, Fayad ZA. Molecular imaging of macrophages in atherosclerotic plaques using bimodal PEG-micelles. Magn Reson Med. 2007 Dec; 58(6):1164-70.
      View in: PubMed
    148. Kramer CM, Budoff MJ, Fayad ZA, Ferrari VA, Goldman C, Lesser JR, Martin ET, Rajagopalan S, Reilly JP, Rodgers GP, Wechsler L. ACCF/AHA 2007 Clinical Competence Statement on vascular imaging with computed tomography and magnetic resonance. Vasc Med. 2007 Nov; 12(4):359-78.
      View in: PubMed
    149. Rudd JH, Myers KS, Sanz J, Fayad ZA. Multimodality imaging of atherosclerosis (magnetic resonance imaging/computed tomography/positron emission tomography-computed tomography). Top Magn Reson Imaging. 2007 Oct; 18(5):379-88.
      View in: PubMed
    150. Mulder WJ, Strijkers GJ, Vucic E, Cormode DP, Nicolay K, Fayad ZA. Magnetic resonance molecular imaging contrast agents and their application in atherosclerosis. Top Magn Reson Imaging. 2007 Oct; 18(5):409-17.
      View in: PubMed
    151. Momiyama Y, Fayad ZA. Aortic plaque imaging and monitoring atherosclerotic plaque interventions. Top Magn Reson Imaging. 2007 Oct; 18(5):349-55.
      View in: PubMed
    152. Kramer CM, Budoff MJ, Fayad ZA, Ferrari VA, Goldman C, Lesser JR, Martin ET, Rajagopalan S, Reilly JP, Rodgers GP, Wechsler L, Creager MA, Holmes DR, Merli G, Newby LK, Piña I, Rodgers GP, Weitz HH. ACCF/AHA 2007 clinical competence statement on vascular imaging with computed tomography and magnetic resonance. A report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training. J Am Coll Cardiol. 2007 Sep 11; 50(11):1097-114.
      View in: PubMed
    153. Briley-Saebo KC, Mulder WJ, Mani V, Hyafil F, Amirbekian V, Aguinaldo JG, Fisher EA, Fayad ZA. Magnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes. J Magn Reson Imaging. 2007 Sep; 26(3):460-79.
      View in: PubMed
    154. ACCF/AHA 2007 clinical competence statement on vascular imaging with computed tomography and magnetic resonance: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training: developed in collaboration with the Society of Atherosclerosis Imaging and Prevention, the Society for Cardiovascular Angiography and Interventions, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society for Vascular Medicine and Biology. Circulation. 2007 Sep 11; 116(11):1318-35.
      View in: PubMed
    155. Rudd JH, Myers KS, Bansilal S, Machac J, Rafique A, Farkouh M, Fuster V, Fayad ZA. (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol. 2007 Aug 28; 50(9):892-6.
      View in: PubMed
    156. Worthley SG, Reis ED, Helft G, Worthley MI, Fayad ZA. Serial magnetic resonance imaging correlates with neurological outcome in an experimental model of spinal cord ischemia. Spinal Cord. 2008 Mar; 46(3):222-7.
      View in: PubMed
    157. Mulder WJ, Griffioen AW, Strijkers GJ, Cormode DP, Nicolay K, Fayad ZA. Magnetic and fluorescent nanoparticles for multimodality imaging. Nanomedicine (Lond). 2007 Jun; 2(3):307-24.
      View in: PubMed
    158. Meding J, Urich M, Licha K, Reinhardt M, Misselwitz B, Fayad ZA, Weinmann HJ. Magnetic resonance imaging of atherosclerosis by targeting extracellular matrix deposition with Gadofluorine M. Contrast Media Mol Imaging. 2007 May-Jun; 2(3):120-9.
      View in: PubMed
    159. Weinreb DB, Aguinaldo JG, Feig JE, Fisher EA, Fayad ZA. Non-invasive MRI of mouse models of atherosclerosis. NMR Biomed. 2007 May; 20(3):256-64.
      View in: PubMed
    160. Rudd JH, Machac J, Fayad ZA. Simvastatin and plaque inflammation. J Am Coll Cardiol. 2007 May 15; 49(19):1991; author reply 1991-2.
      View in: PubMed
    161. Hyafil F, Cornily JC, Feig JE, Gordon R, Vucic E, Amirbekian V, Fisher EA, Fuster V, Feldman LJ, Fayad ZA. Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nat Med. 2007 May; 13(5):636-41.
      View in: PubMed
    162. Amirbekian V, Lipinski MJ, Briley-Saebo KC, Amirbekian S, Aguinaldo JG, Weinreb DB, Vucic E, Frias JC, Hyafil F, Mani V, Fisher EA, Fayad ZA. Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI. Proc Natl Acad Sci U S A. 2007 Jan 16; 104(3):961-6.
      View in: PubMed
    163. Ayaori M, Momiyama Y, Fayad ZA, Yonemura A, Ohmori R, Kihara T, Tanaka N, Nakaya K, Ogura M, Sawada S, Taniguchi H, Kusuhara M, Nagata M, Nakamura H, Ohsuzu F. Effect of bezafibrate therapy on atherosclerotic aortic plaques detected by MRI in dyslipidemic patients with hypertriglyceridemia. Atherosclerosis. 2008 Jan; 196(1):425-33.
      View in: PubMed
    164. Ashida K, Momiyama Y, Fayad ZA, Tanaka N, Kato R, Taniguchi H, Ohmori R, Kihara T, Kameyama A, Nagata M, Nakamura H, Ohsuzu F. Magnetic resonance evaluation of the associations of thoracic and abdominal aortic plaques with the presence and extent of coronary artery stenosis. J Cardiovasc Magn Reson. 2007; 9(6):855-61.
      View in: PubMed
    165. Briley-Saebo KC, Amirbekian V, Mani V, Aguinaldo JG, Vucic E, Carpenter D, Amirbekian S, Fayad ZA. Gadolinium mixed-micelles: effect of the amphiphile on in vitro and in vivo efficacy in apolipoprotein E knockout mouse models of atherosclerosis. Magn Reson Med. 2006 Dec; 56(6):1336-46.
      View in: PubMed
    166. Rudd JH, Fayad ZA, Machac J, Weissberg PL, Davies JR, Warburton EA, Tawakol AA, Strauss HW, Fuster V. Response to 'Laurberg JM, Olsen AK, Hansen SB, et al. Imaging of vulnerable atherosclerotic plaques with FDG-microPET: no FDG accumulation' [Atherosclerosis 2006]. Atherosclerosis. 2007 Jun; 192(2):453-4; author reply 451-2.
      View in: PubMed
    167. Anderson RW, Stomberg C, Hahm CW, Mani V, Samber DD, Itskovich VV, Valera-Guallar L, Fallon JT, Nedanov PB, Huizenga J, Fayad ZA. Automated classification of atherosclerotic plaque from magnetic resonance images using predictive models. Biosystems. 2007 Sep-Oct; 90(2):456-66.
      View in: PubMed
    168. Mani V, Briley-Saebo KC, Hyafil F, Fayad ZA. Feasibility of in vivo identification of endogenous ferritin with positive contrast MRI in rabbit carotid crush injury using GRASP. Magn Reson Med. 2006 Nov; 56(5):1096-106.
      View in: PubMed
    169. Cornily JC, Fayad ZA. Can 32-detector-row CT exclude significant stenoses in coronary artery disease patients with high calcium scores? Nat Clin Pract Cardiovasc Med. 2006 Oct; 3(10):534-5.
      View in: PubMed
    170. Frias JC, Ma Y, Williams KJ, Fayad ZA, Fisher EA. Properties of a versatile nanoparticle platform contrast agent to image and characterize atherosclerotic plaques by magnetic resonance imaging. Nano Lett. 2006 Oct; 6(10):2220-4.
      View in: PubMed
    171. Lipinski MJ, Frias JC, Fayad ZA. Advances in detection and characterization of atherosclerosis using contrast agents targeting the macrophage. J Nucl Cardiol. 2006 Sep; 13(5):699-709.
      View in: PubMed
    172. Dellegrottaglie S, Fayad ZA. Does the combination of stress perfusion and delayed-enhancement MRI improve the detection of CAD? Nat Clin Pract Cardiovasc Med. 2006 Sep; 3(9):472-3.
      View in: PubMed
    173. Lipinski MJ, Amirbekian V, Frias JC, Aguinaldo JG, Mani V, Briley-Saebo KC, Fuster V, Fallon JT, Fisher EA, Fayad ZA. MRI to detect atherosclerosis with gadolinium-containing immunomicelles targeting the macrophage scavenger receptor. Magn Reson Med. 2006 Sep; 56(3):601-10.
      View in: PubMed
    174. Sirol M, Fuster V, Fayad ZA. Plaque imaging and characterization using magnetic resonance imaging: towards molecular assessment. Curr Mol Med. 2006 Aug; 6(5):541-8.
      View in: PubMed
    175. Briley-Saebo KC, Johansson LO, Hustvedt SO, Haldorsen AG, Bjørnerud A, Fayad ZA, Ahlstrom HK. Clearance of iron oxide particles in rat liver: effect of hydrated particle size and coating material on liver metabolism. Invest Radiol. 2006 Jul; 41(7):560-71.
      View in: PubMed
    176. Naghavi M, Falk E, Hecht HS, Jamieson MJ, Kaul S, Berman D, Fayad Z, Budoff MJ, Rumberger J, Naqvi TZ, Shaw LJ, Faergeman O, Cohn J, Bahr R, Koenig W, Demirovic J, Arking D, Herrera VL, Badimon J, Goldstein JA, Rudy Y, Airaksinen J, Schwartz RS, Riley WA, Mendes RA, Douglas P, Shah PK. From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol. 2006 Jul 17; 98(2A):2H-15H.
      View in: PubMed
    177. Koktzoglou I, Chung YC, Mani V, Carroll TJ, Morasch MD, Mizsei G, Simonetti OP, Fayad ZA, Li D. Multislice dark-blood carotid artery wall imaging: a 1.5 T and 3.0 T comparison. J Magn Reson Imaging. 2006 May; 23(5):699-705.
      View in: PubMed
    178. Budoff MJ, Achenbach S, Fayad Z, Berman DS, Poon M, Taylor AJ, Uretsky BF, Williams KA. Task Force 12: training in advanced cardiovascular imaging (computed tomography): endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Atherosclerosis Imaging and Prevention, and Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2006 Feb 21; 47(4):915-20.
      View in: PubMed
    179. Fayad ZA, Amirbekian V, Toussaint JF, Fuster V. Identification of interleukin-2 for imaging atherosclerotic inflammation. Eur J Nucl Med Mol Imaging. 2006 Feb; 33(2):111-6.
      View in: PubMed
    180. Momiyama Y, Kato R, Fayad ZA, Tanaka N, Taniguchi H, Ohmori R, Kihara T, Kameyama A, Miyazaki K, Kimura K, Arakawa K, Kusuhara M, Nagata M, Nakamura H, Ohsuzu F. A possible association between coronary plaque instability and complex plaques in abdominal aorta. Arterioscler Thromb Vasc Biol. 2006 Apr; 26(4):903-9.
      View in: PubMed
    181. Leber AW, Becker A, Knez A, von Ziegler F, Sirol M, Nikolaou K, Ohnesorge B, Fayad ZA, Becker CR, Reiser M, Steinbeck G, Boekstegers P. Accuracy of 64-slice computed tomography to classify and quantify plaque volumes in the proximal coronary system: a comparative study using intravascular ultrasound. J Am Coll Cardiol. 2006 Feb 7; 47(3):672-7.
      View in: PubMed
    182. Mani V, Aguiar SH, Itskovich VV, Weinshelbaum KB, Postley JE, Wasenda EJ, Aguinaldo JG, Samber DD, Fayad ZA. Carotid black blood MRI burden of atherosclerotic disease assessment correlates with ultrasound intima-media thickness. J Cardiovasc Magn Reson. 2006; 8(3):529-34.
      View in: PubMed
    183. Mani V, Briley-Saebo KC, Itskovich VV, Samber DD, Fayad ZA. Gradient echo acquisition for superparamagnetic particles with positive contrast (GRASP): sequence characterization in membrane and glass superparamagnetic iron oxide phantoms at 1.5T and 3T. Magn Reson Med. 2006 Jan; 55(1):126-35.
      View in: PubMed
    184. Sun Q, Wang A, Jin X, Natanzon A, Duquaine D, Brook RD, Aguinaldo JG, Fayad ZA, Fuster V, Lippmann M, Chen LC, Rajagopalan S. Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model. JAMA. 2005 Dec 21; 294(23):3003-10.
      View in: PubMed
    185. Raggi P, Taylor A, Fayad Z, O'Leary D, Nissen S, Rader D, Shaw LJ. Atherosclerotic plaque imaging: contemporary role in preventive cardiology. Arch Intern Med. 2005 Nov 14; 165(20):2345-53.
      View in: PubMed
    186. Mani V, Itskovich VV, Aguiar SH, Mizsei G, Aguinaldo JG, Samber DD, Macaluso FM, Fayad ZA. Comparison of gated and non-gated fast multislice black-blood carotid imaging using rapid extended coverage and inflow/outflow saturation techniques. J Magn Reson Imaging. 2005 Nov; 22(5):628-33.
      View in: PubMed
    187. Fuster V, Fayad ZA, Moreno PR, Poon M, Corti R, Badimon JJ. Atherothrombosis and high-risk plaque: Part II: approaches by noninvasive computed tomographic/magnetic resonance imaging. J Am Coll Cardiol. 2005 Oct 4; 46(7):1209-18.
      View in: PubMed
    188. Fuster V, Moreno PR, Fayad ZA, Corti R, Badimon JJ. Atherothrombosis and high-risk plaque: part I: evolving concepts. J Am Coll Cardiol. 2005 Sep 20; 46(6):937-54.
      View in: PubMed
    189. Sirol M, Fuster V, Badimon JJ, Fallon JT, Moreno PR, Toussaint JF, Fayad ZA. Chronic thrombus detection with in vivo magnetic resonance imaging and a fibrin-targeted contrast agent. Circulation. 2005 Sep 13; 112(11):1594-600.
      View in: PubMed
    190. Corti R, Fuster V, Fayad ZA, Worthley SG, Helft G, Chaplin WF, Muntwyler J, Viles-Gonzalez JF, Weinberger J, Smith DA, Mizsei G, Badimon JJ. Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J Am Coll Cardiol. 2005 Jul 5; 46(1):106-12.
      View in: PubMed
    191. Taylor A, Shaw LJ, Fayad Z, O'Leary D, Brown BG, Nissen S, Rader D, Raggi P. Tracking atherosclerosis regression: a clinical tool in preventive cardiology. Atherosclerosis. 2005 May; 180(1):1-10.
      View in: PubMed
    192. McMahan CA, Gidding SS, Fayad ZA, Zieske AW, Malcom GT, Tracy RE, Strong JP, McGill HC. Risk scores predict atherosclerotic lesions in young people. Arch Intern Med. 2005 Apr 25; 165(8):883-90.
      View in: PubMed
    193. Sirol M, Aguinaldo JG, Graham PB, Weisskoff R, Lauffer R, Mizsei G, Chereshnev I, Fallon JT, Reis E, Fuster V, Toussaint JF, Fayad ZA. Fibrin-targeted contrast agent for improvement of in vivo acute thrombus detection with magnetic resonance imaging. Atherosclerosis. 2005 Sep; 182(1):79-85.
      View in: PubMed
    194. Nikolaou K, Sanz J, Poon M, Wintersperger BJ, Ohnesorge B, Rius T, Fayad ZA, Reiser MF, Becker CR. Assessment of myocardial perfusion and viability from routine contrast-enhanced 16-detector-row computed tomography of the heart: preliminary results. Eur Radiol. 2005 May; 15(5):864-71.
      View in: PubMed
    195. Wentzel JJ, Corti R, Fayad ZA, Wisdom P, Macaluso F, Winkelman MO, Fuster V, Badimon JJ. Does shear stress modulate both plaque progression and regression in the thoracic aorta? Human study using serial magnetic resonance imaging. J Am Coll Cardiol. 2005 Mar 15; 45(6):846-54.
      View in: PubMed
    196. Yonemura A, Momiyama Y, Fayad ZA, Ayaori M, Ohmori R, Higashi K, Kihara T, Sawada S, Iwamoto N, Ogura M, Taniguchi H, Kusuhara M, Nagata M, Nakamura H, Tamai S, Ohsuzu F. Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging. J Am Coll Cardiol. 2005 Mar 1; 45(5):733-42.
      View in: PubMed
    197. Frias JC, Williams KJ, Fisher EA, Fayad ZA. Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques. J Am Chem Soc. 2004 Dec 22; 126(50):16316-7.
      View in: PubMed
    198. Choudhury RP, Fuster V, Fayad ZA. Molecular, cellular and functional imaging of atherothrombosis. Nat Rev Drug Discov. 2004 Nov; 3(11):913-25.
      View in: PubMed
    199. Lipinski MJ, Fuster V, Fisher EA, Fayad ZA. Technology insight: targeting of biological molecules for evaluation of high-risk atherosclerotic plaques with magnetic resonance imaging. Nat Clin Pract Cardiovasc Med. 2004 Nov; 1(1):48-55.
      View in: PubMed
    200. Viles-Gonzalez JF, Poon M, Sanz J, Rius T, Nikolaou K, Fayad ZA, Fuster V, Badimon JJ. In vivo 16-slice, multidetector-row computed tomography for the assessment of experimental atherosclerosis: comparison with magnetic resonance imaging and histopathology. Circulation. 2004 Sep 14; 110(11):1467-72.
      View in: PubMed
    201. Itskovich VV, Samber DD, Mani V, Aguinaldo JG, Fallon JT, Tang CY, Fuster V, Fayad ZA. Quantification of human atherosclerotic plaques using spatially enhanced cluster analysis of multicontrast-weighted magnetic resonance images. Magn Reson Med. 2004 Sep; 52(3):515-23.
      View in: PubMed
    202. Nikolaou K, Becker CR, Flohr T, Huber A, Scheidler J, Fayad ZA, Reiser MF. Optimization of ex vivo CT- and MR- imaging of atherosclerotic vessel wall changes. Int J Cardiovasc Imaging. 2004 Aug; 20(4):327-34.
      View in: PubMed
    203. Trogan E, Fayad ZA, Itskovich VV, Aguinaldo JG, Mani V, Fallon JT, Chereshnev I, Fisher EA. Serial studies of mouse atherosclerosis by in vivo magnetic resonance imaging detect lesion regression after correction of dyslipidemia. Arterioscler Thromb Vasc Biol. 2004 Sep; 24(9):1714-9.
      View in: PubMed
    204. Taniguchi H, Momiyama Y, Fayad ZA, Ohmori R, Ashida K, Kihara T, Hara A, Arakawa K, Kameyama A, Noya K, Nagata M, Nakamura H, Ohsuzu F. In vivo magnetic resonance evaluation of associations between aortic atherosclerosis and both risk factors and coronary artery disease in patients referred for coronary angiography. Am Heart J. 2004 Jul; 148(1):137-43.
      View in: PubMed
    205. Mani V, Itskovich VV, Szimtenings M, Aguinaldo JG, Samber DD, Mizsei G, Fayad ZA. Rapid extended coverage simultaneous multisection black-blood vessel wall MR imaging. Radiology. 2004 Jul; 232(1):281-8.
      View in: PubMed
    206. Sirol M, Itskovich VV, Mani V, Aguinaldo JG, Fallon JT, Misselwitz B, Weinmann HJ, Fuster V, Toussaint JF, Fayad ZA. Lipid-rich atherosclerotic plaques detected by gadofluorine-enhanced in vivo magnetic resonance imaging. Circulation. 2004 Jun 15; 109(23):2890-6.
      View in: PubMed
    207. Rutt BK, Clarke SE, Fayad ZA. Atherosclerotic plaque characterization by MR imaging. Curr Drug Targets Cardiovasc Haematol Disord. 2004 Jun; 4(2):147-59.
      View in: PubMed
    208. Nikolaou K, Becker CR, Muders M, Babaryka G, Scheidler J, Flohr T, Loehrs U, Reiser MF, Fayad ZA. Multidetector-row computed tomography and magnetic resonance imaging of atherosclerotic lesions in human ex vivo coronary arteries. Atherosclerosis. 2004 Jun; 174(2):243-52.
      View in: PubMed
    209. Fayad ZA, Sirol M, Nikolaou K, Choudhury RP, Fuster V. Magnetic resonance imaging and computed tomography in assessment of atherosclerotic plaque. Curr Atheroscler Rep. 2004 May; 6(3):232-42.
      View in: PubMed
    210. Itskovich VV, Mani V, Mizsei G, Aguinaldo JG, Samber DD, Macaluso F, Wisdom P, Fayad ZA. Parallel and nonparallel simultaneous multislice black-blood double inversion recovery techniques for vessel wall imaging. J Magn Reson Imaging. 2004 Apr; 19(4):459-67.
      View in: PubMed
    211. Weintraub AS, Lin X, Itskovich VV, Aguinaldo JG, Chaplin WF, Denhardt DT, Fayad ZA. Prenatal detection of embryo resorption in osteopontin-deficient mice using serial noninvasive magnetic resonance microscopy. Pediatr Res. 2004 Mar; 55(3):419-24.
      View in: PubMed
    212. Sirol M, Fuster V, Toussaint JF, Fayad ZA. Molecular imaging for the diagnosis of high-risk plaque. Arch Mal Coeur Vaiss. 2003 Dec; 96(12):1219-24.
      View in: PubMed
    213. Nikolaou K, Poon M, Sirol M, Becker CR, Fayad ZA. Complementary results of computed tomography and magnetic resonance imaging of the heart and coronary arteries: a review and future outlook. Cardiol Clin. 2003 Nov; 21(4):639-55.
      View in: PubMed
    214. Fatterpekar GM, Delman BN, Boonn WW, Gultekin SH, Fayad ZA, Hoff PR, Naidich TP. MR microscopy of normal human brain. Magn Reson Imaging Clin N Am. 2003 Nov; 11(4):641-53.
      View in: PubMed
    215. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W, Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation. 2003 Oct 14; 108(15):1772-8.
      View in: PubMed
    216. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Juhani Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W, Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation. 2003 Oct 7; 108(14):1664-72.
      View in: PubMed
    217. Fayad ZA, Choudhury RP, Fuster V. Magnetic resonance imaging of coronary atherosclerosis. Curr Atheroscler Rep. 2003 Sep; 5(5):411-7.
      View in: PubMed
    218. Fuster V, Corti R, Fayad ZA, Schwitter J, Badimon JJ. Integration of vascular biology and magnetic resonance imaging in the understanding of atherothrombosis and acute coronary syndromes. J Thromb Haemost. 2003 Jul; 1(7):1410-21.
      View in: PubMed
    219. Gomberg-Maitland M, Fuster V, Fayad ZA, Badimon JJ, Corti R. Statins and plaque stability. J Cardiovasc Risk. 2003 Jun; 10(3):161-7.
      View in: PubMed
    220. Chereshnev I, Trogan E, Omerhodzic S, Itskovich V, Aguinaldo JG, Fayad ZA, Fisher EA, Reis ED. Mouse model of heterotopic aortic arch transplantation. J Surg Res. 2003 May 15; 111(2):171-6.
      View in: PubMed
    221. Itskovich VV, Lieb M, Aguinaldo JG, Samber DD, Ramirez F, Fayad ZA. Magnetic resonance microscopy quantifies the disease progression in Marfan syndrome mice. J Magn Reson Imaging. 2003 Apr; 17(4):435-9.
      View in: PubMed
    222. Wentzel JJ, Aguiar SH, Fayad ZA. Vascular MRI in the diagnosis and therapy of the high risk atherosclerotic plaque. J Interv Cardiol. 2003 Apr; 16(2):129-42.
      View in: PubMed
    223. Worthley SG, Helft G, Fuster V, Fayad ZA, Shinnar M, Minkoff LA, Schechter C, Fallon JT, Badimon JJ. A novel nonobstructive intravascular MRI coil: in vivo imaging of experimental atherosclerosis. Arterioscler Thromb Vasc Biol. 2003 Feb 1; 23(2):346-50.
      View in: PubMed
    224. Choudhury RP, Fayad ZA, Aguinaldo JG, Itskovich VV, Rong JX, Fallon JT, Fisher EA. Serial, noninvasive, in vivo magnetic resonance microscopy detects the development of atherosclerosis in apolipoprotein E-deficient mice and its progression by arterial wall remodeling. J Magn Reson Imaging. 2003 Feb; 17(2):184-9.
      View in: PubMed
    225. Itskovich VV, Choudhury RP, Aguinaldo JG, Fallon JT, Omerhodzic S, Fisher EA, Fayad ZA. Characterization of aortic root atherosclerosis in ApoE knockout mice: high-resolution in vivo and ex vivo MRM with histological correlation. Magn Reson Med. 2003 Feb; 49(2):381-5.
      View in: PubMed
    226. Fayad ZA. MR imaging for the noninvasive assessment of atherothrombotic plaques. Magn Reson Imaging Clin N Am. 2003 Feb; 11(1):101-13.
      View in: PubMed
    227. Corti R, Fuster V, Fayad ZA, Worthley SG, Helft G, Smith D, Weinberger J, Wentzel J, Mizsei G, Mercuri M, Badimon JJ. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation. 2002 Dec 3; 106(23):2884-7.
      View in: PubMed
    228. Poon M, Fuster V, Fayad Z. Cardiac magnetic resonance imaging: a "one-stop-shop" evaluation of myocardial dysfunction. Curr Opin Cardiol. 2002 Nov; 17(6):663-70.
      View in: PubMed
    229. Fayad ZA, Fuster V, Nikolaou K, Becker C. Computed tomography and magnetic resonance imaging for noninvasive coronary angiography and plaque imaging: current and potential future concepts. Circulation. 2002 Oct 8; 106(15):2026-34.
      View in: PubMed
    230. Choudhury RP, Fayad ZA. Imaging of atherosclerosis. Coronary wall imaging with MRI. J Cardiovasc Risk. 2002 Oct; 9(5):263-70.
      View in: PubMed
    231. Fatterpekar GM, Naidich TP, Delman BN, Aguinaldo JG, Gultekin SH, Sherwood CC, Hof PR, Drayer BP, Fayad ZA. Cytoarchitecture of the human cerebral cortex: MR microscopy of excised specimens at 9.4 Tesla. AJNR Am J Neuroradiol. 2002 Sep; 23(8):1313-21.
      View in: PubMed
    232. Fayad ZA. Noncoronary and coronary atherothrombotic plaque imaging and monitoring of therapy by MRI. Neuroimaging Clin N Am. 2002 Aug; 12(3):461-71.
      View in: PubMed
    233. Fayad ZA, Fuster V. Atherothrombotic plaques and the need for imaging. Neuroimaging Clin N Am. 2002 Aug; 12(3):351-64.
      View in: PubMed
    234. Choudhury RP, Fuster V, Badimon JJ, Fisher EA, Fayad ZA. MRI and characterization of atherosclerotic plaque: emerging applications and molecular imaging. Arterioscler Thromb Vasc Biol. 2002 Jul 1; 22(7):1065-74.
      View in: PubMed
    235. Choudhury RP, Aguinaldo JG, Rong JX, Kulak JL, Kulak AR, Reis ED, Fallon JT, Fuster V, Fisher EA, Fayad ZA. Atherosclerotic lesions in genetically modified mice quantified in vivo by non-invasive high-resolution magnetic resonance microscopy. Atherosclerosis. 2002 Jun; 162(2):315-21.
      View in: PubMed
    236. Corti R, Osende JI, Fayad ZA, Fallon JT, Fuster V, Mizsei G, Dickstein E, Drayer B, Badimon JJ. In vivo noninvasive detection and age definition of arterial thrombus by MRI. J Am Coll Cardiol. 2002 Apr 17; 39(8):1366-73.
      View in: PubMed
    237. Baim D, Brady TJ, Casscells SW, Dunne M, Fayad Z, Fuster V, Gazelle S, Heldman A, Hatsukami T, Kinlay S, Lafont A, Lee R, Libby P, Meier B, Muller JE, Naghavi M, O'Donnell C, Perin E, Rekhter M, Rumberger J, Russell M, Schwartz R, Selwyn A, Strauss HW, Tearney G, Tomaru T, Tuzcu EM, Wasserman B. Thoughts on the role of the healing professions and the events of September 11, 2001. Circulation. 2002 Mar 26; 105(12):1509-10.
      View in: PubMed
    238. Helft G, Worthley SG, Fuster V, Fayad ZA, Zaman AG, Corti R, Fallon JT, Badimon JJ. Progression and regression of atherosclerotic lesions: monitoring with serial noninvasive magnetic resonance imaging. Circulation. 2002 Feb 26; 105(8):993-8.
      View in: PubMed
    239. Worthley SG, Fayad ZA. Utility of cardiovascular magnetic resonance imaging. Heart Lung Circ. 2002; 11(1):63.
      View in: PubMed
    240. Corti R, Fuster V, Badimon JJ, Hutter R, Fayad ZA. New understanding of atherosclerosis (clinically and experimentally) with evolving MRI technology in vivo. Ann N Y Acad Sci. 2001 Dec; 947:181-95; discussion 195-8.
      View in: PubMed
    241. Reis ED, Li J, Fayad ZA, Rong JX, Hansoty D, Aguinaldo JG, Fallon JT, Fisher EA. Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E-deficient mouse in a novel transplantation model. J Vasc Surg. 2001 Sep; 34(3):541-7.
      View in: PubMed
    242. Fayad ZA, Fuster V. Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circ Res. 2001 Aug 17; 89(4):305-16.
      View in: PubMed
    243. Fayad ZA, Fuster V. The human high-risk plaque and its detection by magnetic resonance imaging. Am J Cardiol. 2001 Jul 19; 88(2A):42E-45E.
      View in: PubMed
    244. Corti R, Fayad ZA, Fuster V, Worthley SG, Helft G, Chesebro J, Mercuri M, Badimon JJ. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation. 2001 Jul 17; 104(3):249-52.
      View in: PubMed
    245. Fayad ZA. The assessment of the vulnerable atherosclerotic plaque using MR imaging: a brief review. Int J Cardiovasc Imaging. 2001 Jun; 17(3):165-77.
      View in: PubMed
    246. Worthley SG, Helft G, Fayad ZA, Fuster V, Rodriguez OJ, Zaman AG, Badimon JJ. Cardiac gated breath-hold black blood MRI of the coronary artery wall: an in vivo and ex vivo comparison. Int J Cardiovasc Imaging. 2001 Jun; 17(3):195-201.
      View in: PubMed
    247. Corti R, Osende JI, Fuster V, Fayad ZA, Fallon JT, Badimon JJ. Artery dissection and arterial thrombus aging: the role of noninvasive magnetic resonance imaging. Circulation. 2001 May 15; 103(19):2420-1.
      View in: PubMed
    248. Helft G, Worthley SG, Fuster V, Zaman AG, Schechter C, Osende JI, Rodriguez OJ, Fayad ZA, Fallon JT, Badimon JJ. Atherosclerotic aortic component quantification by noninvasive magnetic resonance imaging: an in vivo study in rabbits. J Am Coll Cardiol. 2001 Mar 15; 37(4):1149-54.
      View in: PubMed
    249. Rauch U, Osende JI, Fuster V, Badimon JJ, Fayad Z, Chesebro JH. Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences. Ann Intern Med. 2001 Feb 6; 134(3):224-38.
      View in: PubMed
    250. Fayad ZA, Fuster V, Fallon JT, Jayasundera T, Worthley SG, Helft G, Aguinaldo JG, Badimon JJ, Sharma SK. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation. 2000 Aug 1; 102(5):506-10.
      View in: PubMed
    251. Worthley SG, Helft G, Fuster V, Fayad ZA, Rodriguez OJ, Zaman AG, Fallon JT, Badimon JJ. Noninvasive in vivo magnetic resonance imaging of experimental coronary artery lesions in a porcine model. Circulation. 2000 Jun 27; 101(25):2956-61.
      View in: PubMed
    252. Worthley SG, Helft G, Fayad ZA, Fuster V, Zaman AG, Shinnar M, Badimon JJ. Images in cardiovascular medicine. Magnetic resonance imaging and asymptomatic aortic dissection. Circulation. 2000 Jun 13; 101(23):2771.
      View in: PubMed
    253. Worthley SG, Helft G, Fuster V, Fayad ZA, Fallon JT, Osende JI, Roqué M, Shinnar M, Zaman AG, Rodriguez OJ, Verhallen P, Badimon JJ. High resolution ex vivo magnetic resonance imaging of in situ coronary and aortic atherosclerotic plaque in a porcine model. Atherosclerosis. 2000 Jun; 150(2):321-9.
      View in: PubMed
    254. Fayad ZA, Nahar T, Fallon JT, Goldman M, Aguinaldo JG, Badimon JJ, Shinnar M, Chesebro JH, Fuster V. In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography. Circulation. 2000 May 30; 101(21):2503-9.
      View in: PubMed
    255. Fayad ZA, Fuster V. Characterization of atherosclerotic plaques by magnetic resonance imaging. Ann N Y Acad Sci. 2000 May; 902:173-86.
      View in: PubMed
    256. Worthley SG, Helft G, Fuster V, Zaman AG, Fayad ZA, Fallon JT, Badimon JJ. Serial in vivo MRI documents arterial remodeling in experimental atherosclerosis. Circulation. 2000 Feb 15; 101(6):586-9.
      View in: PubMed
    257. Fischer A, Gutstein DE, Fayad ZA, Fuster V. Predicting plaque rupture: enhancing diagnosis and clinical decision-making in coronary artery disease. Vasc Med. 2000; 5(3):163-72.
      View in: PubMed
    258. Shinnar M, Fallon JT, Wehrli S, Levin M, Dalmacy D, Fayad ZA, Badimon JJ, Harrington M, Harrington E, Fuster V. The diagnostic accuracy of ex vivo MRI for human atherosclerotic plaque characterization. Arterioscler Thromb Vasc Biol. 1999 Nov; 19(11):2756-61.
      View in: PubMed
    259. Badimon JJ, Zaman A, Helft G, Fayad Z, Fuster V. Acute coronary syndromes: pathophysiology and preventive priorities. Thromb Haemost. 1999 Aug; 82(2):997-1004.
      View in: PubMed
    260. Fuster V, Fayad ZA, Badimon JJ. Acute coronary syndromes: biology. Lancet. 1999 Jun; 353 Suppl 2:SII5-9.
      View in: PubMed
    261. Scott CH, Sutton MS, Gusani N, Fayad Z, Kraitchman D, Keane MG, Axel L, Ferrari VA. Effect of dobutamine on regional left ventricular function measured by tagged magnetic resonance imaging in normal subjects. Am J Cardiol. 1999 Feb 1; 83(3):412-7.
      View in: PubMed
    262. Fayad ZA, Fallon JT, Shinnar M, Wehrli S, Dansky HM, Poon M, Badimon JJ, Charlton SA, Fisher EA, Breslow JL, Fuster V. Noninvasive In vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice. Circulation. 1998 Oct 13; 98(15):1541-7.
      View in: PubMed
    263. Kraitchman DL, Young AA, Bloomgarden DC, Fayad ZA, Dougherty L, Ferrari VA, Boston RC, Axel L. Integrated MRI assessment of regional function and perfusion in canine myocardial infarction. Magn Reson Med. 1998 Aug; 40(2):311-26.
      View in: PubMed
    264. Fayad ZA, Ferrari VA, Kraitchman DL, Young AA, Palevsky HI, Bloomgarden DC, Axel L. Right ventricular regional function using MR tagging: normals versus chronic pulmonary hypertension. Magn Reson Med. 1998 Jan; 39(1):116-23.
      View in: PubMed
    265. Chin BB, Bloomgarden DC, Xia W, Kim HJ, Fayad ZA, Ferrari VA, Berlin JA, Axel L, Alavi A. Right and left ventricular volume and ejection fraction by tomographic gated blood-pool scintigraphy. J Nucl Med. 1997 Jun; 38(6):942-8.
      View in: PubMed
    266. Bloomgarden DC, Fayad ZA, Ferrari VA, Chin B, Sutton MG, Axel L. Global cardiac function using fast breath-hold MRI: validation of new acquisition and analysis techniques. Magn Reson Med. 1997 May; 37(5):683-92.
      View in: PubMed
    267. Young AA, Fayad ZA, Axel L. Right ventricular midwall surface motion and deformation using magnetic resonance tagging. Am J Physiol. 1996 Dec; 271(6 Pt 2):H2677-88.
      View in: PubMed
    268. Fayad ZA, Connick TJ, Axel L. An improved quadrature or phased-array coil for MR cardiac imaging. Magn Reson Med. 1995 Aug; 34(2):186-93.
      View in: PubMed
    Fayad's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067